Home950210 • KRX
add
Prestige Biopharma Ltd
Previous close
₩12,680.00
Day range
₩12,410.00 - ₩12,810.00
Year range
₩11,000.00 - ₩20,000.00
Market cap
749.40B KRW
Avg Volume
131.56K
P/E ratio
32.93
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2025info | Y/Y change | 
|---|---|---|
| Revenue | 5.53B | 4,131.01% | 
| Operating expense | -7.49B | -235.96% | 
| Net income | -8.78B | 5.48% | 
| Net profit margin | -158.81 | -102.34% | 
| Earnings per share | — | — | 
| EBITDA | -8.10B | -57.79% | 
| Effective tax rate | 2.47% | — | 
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2025info | Y/Y change | 
|---|---|---|
| Cash and short-term investments | 173.71B | -21.92% | 
| Total assets | 745.65B | 4.77% | 
| Total liabilities | 237.34B | 20.96% | 
| Total equity | 508.31B | — | 
| Shares outstanding | 60.19M | — | 
| Price to book | 1.86 | — | 
| Return on assets | -4.40% | — | 
| Return on capital | -5.05% | — | 
Cash Flow
Net change in cash
| (KRW) | Jun 2025info | Y/Y change | 
|---|---|---|
| Net income | -8.78B | 5.48% | 
| Cash from operations | -4.34B | 67.64% | 
| Cash from investing | -13.21B | -178.96% | 
| Cash from financing | -2.42B | -380.26% | 
| Net change in cash | -18.11B | -504.04% | 
| Free cash flow | -20.73B | -360.83% | 
About
Founded
2015
Website
Employees
66
